Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring Changes Aimed at Growing Otsuka's Pharmaceutical Business Worldwide ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

Editor's note: this interview was originally published on BioPharmInternational.com.

Abzena and Mabqi have announced a partnership integrating antibody discovery capabilities with development and manufacturing ...

Dyno Therapeutics and Trisk Bio have announced a strategic manufacturing partnership via former’s expanded Frontiers Program.

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Read more about HRV Pharma and MetroChem Forge Strategic CDMO Alliance to Fast-Track High-Value NCE-1 API Development on Devdiscourse ...

In this episode of the Ask the Expert video series, Susan J. Schniepp, Regulatory Compliance Associates (RCA), Siegfried ...

Pharmaceutical research and development (R&D) has become increasingly challenging for various reasons, including the proliferation of plausible targets to pursue for therapeutic innovation resulting ...

Dublin, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The "A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Training Course (Nov 4, 2025)" training has been added to ...

The biotech sector's record in originating high-priority medicines exceeds that of the pharmaceutical industry, its costs are lower and its products have comparable revenues. The creation of important ...